0000805928-23-000106.txt : 20230825 0000805928-23-000106.hdr.sgml : 20230825 20230825161636 ACCESSION NUMBER: 0000805928-23-000106 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230825 DATE AS OF CHANGE: 20230825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Burke William P. Mr. CENTRAL INDEX KEY: 0001682069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36046 FILM NUMBER: 231208485 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 FORMER NAME: FORMER CONFORMED NAME: Burke Willaim P DATE OF NAME CHANGE: 20160810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Axogen, Inc. CENTRAL INDEX KEY: 0000805928 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411301878 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: (386) 462-6817 MAIL ADDRESS: STREET 1: 13631 PROGRESS BLVD. STREET 2: SUITE 400 CITY: ALACHUA STATE: FL ZIP: 32615 FORMER COMPANY: FORMER CONFORMED NAME: AxoGen, Inc. DATE OF NAME CHANGE: 20111004 FORMER COMPANY: FORMER CONFORMED NAME: LECTEC CORP /MN/ DATE OF NAME CHANGE: 19920703 4 1 wf-form4_169299457138172.xml FORM 4 X0508 4 2023-08-23 0 0000805928 Axogen, Inc. AXGN 0001682069 Burke William P. Mr. C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400 ALACHUA FL 32615 1 0 0 0 0 Common Stock 2023-08-23 4 P 0 10000 6.56 A 10000 I By Spouse Common Stock 2023-08-24 4 A 0 6000 6.31 A 6000 D The reported price in Column 4 is a weighted average purchase price. These shares were purchased in several transactions at prices ranging from $6.54 to $6.57 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $6.28 to $6.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. William Burke 2023-08-25